CGM After Discharge From Hospital

Sex: All

Ages: 18 Years – N/A

Healthy volunteers: No

Phase: NA

Enrollment: 64

Sponsor: Icahn School of Medicine at Mount Sinai

Summary

This is an investigator initiated prospective, randomized controlled trial which aims to compare two groups of patients with either type 2 or steroid-induced diabetes who are discharged with insulin. The intervention group will use the Libre 3 Plus continuous glucose monitoring (CGM) system at discharge, while the control group will use blinded CGM and fingerstick monitoring. Both the intervention and control groups will wear the sensor for 28 days post discharge and participate in telehealth diabetes management visits. The target enrollment for the study is 65 participants and participants are expected to be in the study for up to 35 days.

Eligibility Criteria

Inclusion Criteria: * Adult 18 years or older. * Inpatient treatment for type 2 or steroid induced diabetes during hospitalization, with plan for insulin use after discharge. Exclusion Criteria: * Type 1 diabetes * Plan for discharge to rehabilitation/skilled nursing/hospice facility * Contra-indication to sensor placement * Pregnancy

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07510386). StuddyBuddy aggregates publicly available trial information.